153 related articles for article (PubMed ID: 21261109)
1. [Metformin as the first line antidiabetic agent].
Svacina S
Vnitr Lek; 2010 Dec; 56(12):1225-7. PubMed ID: 21261109
[TBL] [Abstract][Full Text] [Related]
2. Drug therapy in prediabetes.
Mukhopadhyay P; Chowdhury S
J Indian Med Assoc; 2005 Nov; 103(11):603-5, 608. PubMed ID: 16570765
[TBL] [Abstract][Full Text] [Related]
3. Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
Jones MR; Mudaliar S; Hernandez-Triana E; Unnikrishnan AG; Lai YL; Abby SL; Misir S; Jin X; Nagendran S
Curr Med Res Opin; 2009 Sep; 25(9):2239-49. PubMed ID: 19622007
[TBL] [Abstract][Full Text] [Related]
4. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
Bosi E
Diabetes Obes Metab; 2009 May; 11 Suppl 2():3-8. PubMed ID: 19385978
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatment options for prediabetes.
Hsueh WA; Handelsman Y
Nat Clin Pract Endocrinol Metab; 2008 Jul; 4(7):380-1. PubMed ID: 18523427
[No Abstract] [Full Text] [Related]
6. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
7. The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.
Andreadis EA; Katsanou PM; Georgiopoulos DX; Tsourous GI; Yfanti GK; Gouveri ET; Diamantopoulos EJ
Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):175-80. PubMed ID: 19053032
[TBL] [Abstract][Full Text] [Related]
8. [Metformin role in the treatment of type 2 diabetes in 2008].
Spada A; Philippe J
Rev Med Suisse; 2008 Jun; 4(160):1392-4, 1396-7. PubMed ID: 18630062
[TBL] [Abstract][Full Text] [Related]
9. [Diabetes drugs and body weight].
Eriksson J; Laine M
Duodecim; 2013; 129(1):73-8. PubMed ID: 23431885
[TBL] [Abstract][Full Text] [Related]
10. Metformin and cancer: licence to heal?
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Investig Drugs; 2010 Aug; 19(8):913-7. PubMed ID: 20557275
[TBL] [Abstract][Full Text] [Related]
11. [Development of body weight during antidiabetic treatment].
Hamann A
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S255-8. PubMed ID: 17139582
[TBL] [Abstract][Full Text] [Related]
12. Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents.
Goodarzi MO; Bryer-Ash M
Diabetes Obes Metab; 2005 Nov; 7(6):654-65. PubMed ID: 16219009
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
Strowig SM; Raskin P
Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
[TBL] [Abstract][Full Text] [Related]
14. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
Malesker MA
Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus: a retrospective study.
Drzewoski J; Czupryniak L
Med Sci Monit; 2003 Jun; 9(6):CR240-3. PubMed ID: 12824953
[TBL] [Abstract][Full Text] [Related]
16. Current indications for metformin therapy.
Tankova T
Rom J Intern Med; 2003; 41(3):215-25. PubMed ID: 15526505
[TBL] [Abstract][Full Text] [Related]
17. [Anti-cancer activity of metformin: new perspectives for an old drug].
Beck E; Scheen AJ
Rev Med Suisse; 2010 Sep; 6(260):1601-7. PubMed ID: 20853715
[TBL] [Abstract][Full Text] [Related]
18. [Oral antidiabetic therapy].
Schneider S; Pazdzierny G; Klein HH
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S264-7. PubMed ID: 17139584
[TBL] [Abstract][Full Text] [Related]
19. Metformin: old wine in new bottle--evolving technology and therapy in diabetes.
Joshi SR
J Assoc Physicians India; 2005 Nov; 53():963-72. PubMed ID: 16515237
[TBL] [Abstract][Full Text] [Related]
20. Metformin, a promising oral antihyperglycemic for the treatment of noninsulin-dependent diabetes mellitus.
Wildasin EM; Skaar DJ; Kirchain WR; Hulse M
Pharmacotherapy; 1997; 17(1):62-73. PubMed ID: 9017766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
